Abstract
The use of insulin-sensitizing drugs offers a new perspective for the treatment of polycystic ovary syndrome-related reproductive disorders. However, further data are needed before we can draw definitive conclusions regarding their clinical role.
Original language | English |
---|---|
Pages (from-to) | 364-373 |
Number of pages | 10 |
Journal | Current Opinion in Obstetrics and Gynecology |
Volume | 20 |
Issue number | 4 |
DOIs | |
Publication status | Published - Aug 2008 |
Keywords
- Infertility
- Insulin sensitizers
- Metformin
- Ovulation induction
- Polycystic ovary syndrome
- Thiazolidinediones
ASJC Scopus subject areas
- Obstetrics and Gynaecology